Calif. Legislature Sends Biosimilar Drug Bill To Gov.

Law360, Los Angeles (September 4, 2013, 10:54 PM EDT) -- The California state Legislature is sending a bill to Gov. Jerry Brown that would allow pharmacists to substitute biologically similar medicines for higher-cost brand name biologics, the California Healthcare Institute said Wednesday.

The bill, known as SB598, flew through the Senate with a 30-2 vote, the private nonprofit said. The bill would expand permission for dispensing the drugs, which would open up the market for generic medications made up of living cells. Biosimilar medicines can currently only be dispensed by physicians, the organization noted.

“The bill...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.